Cargando…

Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation

Elevated circulating platelet-derived extracellular vesicles (EVs) have been reported in conditions associated with thrombotic risk. The present study aimed to assess the relationship between circulating platelet-derived EV levels, cardiovascular risk stratification and vascular organ damage, as ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lugo-Gavidia, Leslie Marisol, Nolde, Janis M., Carnagarin, Revathy, Burger, Dylan, Chan, Justine, Robinson, Sandi, Bosio, Erika, Matthews, Vance B., Schlaich, Markus P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505165/ https://www.ncbi.nlm.nih.gov/pubmed/36142436 http://dx.doi.org/10.3390/ijms231810524

Ejemplares similares

Circulating platelet‐derived extracellular vesicles correlate with night‐time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health
por: Lugo‐Gavidia, Leslie Marisol, et al.
Publicado: (2022)

Evaluation of Circulating Platelet Extracellular Vesicles and Hypertension Mediated Organ Damage
por: Lugo-Gavidia, Leslie Marisol, et al.
Publicado: (2022)

Sympathetic Activation in Hypertensive Chronic Kidney Disease – A Stimulus for Cardiac Arrhythmias and Sudden Cardiac Death?
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

Machine learning powered tools for automated analysis of muscle sympathetic nerve activity recordings
por: Nolde, Janis M., et al.
Publicado: (2021)

New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Supine blood pressure—A clinically relevant determinant of vascular target organ damage in hypertensive patients
por: Nolde, Janis M., et al.
Publicado: (2020)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy
por: Carnagarin, Revathy, et al.
Publicado: (2021)

Microvascular changes at different stages of chronic kidney disease
por: Kannenkeril, Dennis, et al.
Publicado: (2020)

Renal denervation as a synergistic tool for the treatment of polymorphic ventricular ectopic beats: A case report
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2020)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
por: Carnagarin, Revathy, et al.
Publicado: (2021)

The molecular basis for the neutral effect of renal denervation in patients with chronic heart failure not responding to cardiac resynchronisation therapy – a perspective
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Multi-organ denervation: a novel approach to combat cardiometabolic disease
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2023)

Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension
por: Frost, Shaun, et al.
Publicado: (2021)

Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic Retinopathy
por: Herat, Lakshini Y., et al.
Publicado: (2018)

Female Gender Is Associated with Higher Susceptibility of Weight Induced Arterial Stiffening and Rise in Blood Pressure
por: Zuo, Junli, et al.
Publicado: (2021)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
por: Carnagarin, Revathy, et al.
Publicado: (2019)

Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney Disease
por: Magno, Aaron L., et al.
Publicado: (2019)

Relevance of Targeting the Distal Renal Artery and Branches with Radiofrequency Renal Denervation Approaches—A Secondary Analysis from a Hypertensive CKD Patient Cohort
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Combined renal and common hepatic artery denervation as a novel approach to reduce cardiometabolic risk: technical approach, feasibility and safety in a pre-clinical model
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2021)

The Schlager mouse as a model of altered retinal phenotype
por: Herat, Lakshini Y., et al.
Publicado: (2019)

SGLT2 Inhibitor–Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection
por: Herat, Lakshini Y., et al.
Publicado: (2020)

Platelet to Lymphocyte Percentage Ratio Is Associated With Brachial–Ankle Pulse Wave Velocity in Hemodialysis
por: Chen, Szu-Chia, et al.
Publicado: (2016)

May Measurement Month 2017: an analysis of blood pressure screening results from Australia—South-East Asia and Australasia
por: Carnagarin, Revathy, et al.
Publicado: (2019)

Pulse Wave Velocity in Atherosclerosis
por: Kim, Hack-Lyoung, et al.
Publicado: (2019)

The Impact of SGLT2 Inhibitors in the Heart and Kidneys Regardless of Diabetes Status
por: Matthews, Jennifer, et al.
Publicado: (2023)

Pulmonary pulse wave velocity as assessed with velocity-encoded MRI
por: Grotenhuis, Heynric, et al.
Publicado: (2012)

Implications of ADAM17 activation for hyperglycaemia, obesity and type 2 diabetes
por: Matthews, Jennifer, et al.
Publicado: (2021)

The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney
por: Matthews, Jennifer, et al.
Publicado: (2023)

Determinants of Brachial-Ankle Pulse Wave Velocity and Carotid-Femoral Pulse Wave Velocity in Healthy Koreans
por: Jang, Shin Yi, et al.
Publicado: (2014)

Acute Changes in Carotid-Femoral Pulse-Wave Velocity Are Tracked by Heart-Femoral Pulse-Wave Velocity
por: Stone, Keeron, et al.
Publicado: (2021)

A cautionary note for researchers treating mice with the neurotransmitter norepinephrine
por: Matthews, Vance B., et al.
Publicado: (2018)

Pulse Wave Velocity in Postmenopausal Women
por: Suzuki, Hiromichi, et al.
Publicado: (2013)

Hemodialysis Parameters and Pulse Wave Velocity
por: Miseljic, Sanja, et al.
Publicado: (2022)

Sympathetic stimulation with norepinephrine may come at a cost
por: Herat, Lakshini Y., et al.
Publicado: (2019)

A Comparative Study of Brachial–Ankle Pulse Wave Velocity and Heart–Finger Pulse Wave Velocity in Korean Adults
por: Cho, Jaegeol, et al.
Publicado: (2020)

Novel Methods for Pulse Wave Velocity Measurement
por: Pereira, Tânia, et al.
Publicado: (2015)

Heart-Ankle Pulse Wave Velocity Is Superior to Brachial-Ankle Pulse Wave Velocity in Detecting Aldosterone-Induced Arterial Stiffness
por: Chen, Zheng-Wei, et al.
Publicado: (2021)

Determining the role of SGLT2 inhibition with Empagliflozin in the development of diabetic retinopathy
por: Matthews, Jennifer, et al.
Publicado: (2022)

Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
por: Herat, Lakshini Y., et al.
Publicado: (2022)

Diabetic retinopathy is associated with pulse wave velocity, not with the augmentation index of pulse waveform
por: Ogawa, Osamu, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fpultlrg430plvn0df981e78ru